Raymond M. Reilly

8.4k citations

174 papers · 6.3k indexed · 1 hit paper · h-index 44

Radiology, Nuclear Medicine and Imaging top 0.2%
- Radiopharmaceutical Chemistry and Applications 116
- Monoclonal and Polyclonal Antibodies Research 65
- Medical Imaging Techniques and Applications 20
Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 20
Structural Biology top 2%
Radiation top 1%
Oncology top 1%
- HER2/EGFR in Cancer Research 56
Pulmonary and Respiratory Medicine
- Radiation Therapy and Dosimetry 19
- Lung Cancer Treatments and Mutations 12
Molecular Biology
- RNA Interference and Gene Delivery 11

Co-authors: Zhongli Cai Deborah A. Scollard Jean‐Philippe Pignol Katherine A. Vallis Christine Allen Conrad Chan Niladri Chattopadhyay Bryan Hoang
Cited by: Radiology, Nuclear Medicine and Imaging Biomaterials Structural Biology
Journals: PLoS ONE (2 papers)Cancer Research (1 paper)Advanced Drug Delivery Reviews (1 paper)
Partner nations: Canada United States United Kingdom

In The Last Decade

Raymond M. Reilly

170 papers receiving 6.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Raymond M. Reilly

Since Specialization

Citations

This map shows the geographic impact of Raymond M. Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond M. Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond M. Reilly more than expected).

Fields of papers citing papers by Raymond M. Reilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond M. Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond M. Reilly. The network helps show where Raymond M. Reilly may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raymond M. Reilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raymond M. Reilly Line = papers co-authored together Raymond M. Reilly links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	[225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive human breast cancer xenografts EJNMMI Radiopharmacy and Chemistry ·Misaki Kondo,Zhongli Cai,Conrad Chan,Nubaira Forkan,Raymond M. Reilly	2023	8
2	Adjuvant Auger Electron-Emitting Radioimmunotherapy with [¹¹¹In]In-DOTA-Panitumumab in a Mouse Model of Local Recurrence and Metastatic Progression of Human Triple-Negative Breast Cancer Molecular Pharmaceutics ·Valerie J. Facca,Zhongli Cai,Anthony Ku,Constantine J. Georgiou,Raymond M. Reilly	2023	3
3	Panitumumab-DOTA-¹¹¹In: An Epidermal Growth Factor Receptor Targeted Theranostic for SPECT/CT Imaging and Meitner–Auger Electron Radioimmunotherapy of Triple-Negative Breast Cancer Molecular Pharmaceutics ·Valerie J. Facca,Zhongli Cai,Nakita E. K. Gopal,Raymond M. Reilly	2022	7
4	Changing Surface Polyethylene Glycol Architecture Affects Elongated Nanoparticle Penetration into Multicellular Tumor Spheroids Biomacromolecules ·Megan G. Roberts,Valerie J. Facca,Rachel Keunen,Qing Yu,Raymond M. Reilly,Mitchell A. Winnik	2022	7
5	Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [99mTc]-(I)-Tricarbonyl Complex Molecular Imaging and Biology ·Valerie J. Facca,Noor Al‐saden,Anthony Ku,Raymond M. Reilly	2021	4
6	Investigating the influence of block copolymer micelle length on cellular uptake and penetration in a multicellular tumor spheroid model Nanoscale ·Qing Yu,Megan G. Roberts,Loujin Houdaihed,Yang Liu,Kevin Ho,Gilbert C. Walker,Christine Allen,Raymond M. Reilly,Ian Manners,Mitchell A. Winnik	2020	60
7	Intracellular Routing in Breast Cancer Cells of Streptavidin-Conjugated Trastuzumab Fab Fragments Linked to Biotinylated Doxorubicin-Functionalized Metal Chelating Polymers Biomacromolecules ·Peng Liu,Zhongli Cai,Jae‐Wook Kang,Amanda J. Boyle,Jarrett Adams,Yijie Lu,Ghislaine Ngo Ndjock Mbong,Sachdev S. Sidhu,Raymond M. Reilly,Mitchell A. Winnik	2014	18
8	Auger Electron Radioimmunotherapeutic Agent Specific for the CD123⁺/CD131⁻ Phenotype of the Leukemia Stem Cell Population Journal of Nuclear Medicine ·Jeffrey V. Leyton,Meiduo Hu,Catherine A. Gao,Patricia V. Turner,John E. Dick,Mark D. Minden,Raymond M. Reilly	2011	37
9	Cellular Dosimetry of ¹¹¹In Using Monte Carlo N-Particle Computer Code: Comparison with Analytic Methods and Correlation with In Vitro Cytotoxicity Journal of Nuclear Medicine ·Zhongli Cai,Jean‐Philippe Pignol,Conrad Chan,Raymond M. Reilly	2010	54
10	Monoclonal antibody and peptide-targeted radiotherapy of cancer Wiley eBooks ·Raymond M. Reilly	2010	23
11	Micro-SPECT/CT with ¹¹¹In-DTPA-Pertuzumab Sensitively Detects Trastuzumab-Mediated HER2 Downregulation and Tumor Response in Athymic Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts Journal of Nuclear Medicine ·Kristin McLarty,Bart Cornelissen,Zhongli Cai,Deborah A. Scollard,Danny L. Costantini,Susan J. Done,Raymond M. Reilly	2009	58
12	¹⁸F-FDG Small-Animal PET/CT Differentiates Trastuzumab-Responsive from Unresponsive Human Breast Cancer Xenografts in Athymic Mice Journal of Nuclear Medicine ·Kristin McLarty,Aisha Fasih,Deborah A. Scollard,Susan J. Done,Douglass Vines,David E. Green,Danny L. Costantini,Raymond M. Reilly	2009	33
13	Relationship Between Induction of Phosphorylated H2AX and Survival in Breast Cancer Cells Exposed to ¹¹¹In-DTPA-hEGF Journal of Nuclear Medicine ·Zhongli Cai,Zhuo Chen,Kristy Bailey,Deborah A. Scollard,Raymond M. Reilly,Katherine A. Vallis	2008	50
14	Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron–Emitting Radiotherapeutic Agent ¹¹¹In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate Journal of Nuclear Medicine ·Danny L. Costantini,Katherine Bateman,Kristin McLarty,Katherine A. Vallis,Raymond M. Reilly	2008	66
15	Drug-Resistant AML Cells and Primary AML Specimens Are Killed by ¹¹¹In-Anti-CD33 Monoclonal Antibodies Modified with Nuclear Localizing Peptide Sequences Journal of Nuclear Medicine ·Veerle Kersemans,Bart Cornelissen,Mark D. Minden,Joseph Brandwein,Raymond M. Reilly	2008	32
16	Epidermal Growth Factor Receptor Inhibition Modulates the Nuclear Localization and Cytotoxicity of the Auger Electron Emitting Radiopharmaceutical 111In-DTPA Human Epidermal Growth Factor Journal of Nuclear Medicine ·Kristy Bailey,D. L. Costantini,Zhongli Cai,Deborah A. Scollard,Zhuo Chen,Raymond M. Reilly,Katherine A. Vallis	2007	31
17	111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer Journal of Nuclear Medicine ·D. L. Costantini,Conrad Chan,Zhongli Cai,Katherine A. Vallis,Raymond M. Reilly	2007	148
18	Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [99mTc]-HYNIC-trastuzumab (Herceptin) Fab fragments Nuclear Medicine Communications ·Ying Tang,Deborah A. Scollard,Paul Chen,Judy Wang,Claire Holloway,Raymond M. Reilly	2005	52
19	Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical. PubMed ·Raymond M. Reilly,Jean Gariépy	1998	23
20	The Pharmaceutical Stability of Deferoxamine Mesylate The Canadian Journal of Hospital Pharmacy ·David M. Hayes,Raymond M. Reilly,May M.C. Lee	1994	1

About Raymond M. Reilly

Raymond M. Reilly is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Structural Biology, having authored 174 papers that have together received 6.3k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (116 papers), Monoclonal and Polyclonal Antibodies Research (65 papers), HER2/EGFR in Cancer Research (56 papers), Medical Imaging Techniques and Applications (20 papers), Nanoparticle-Based Drug Delivery (20 papers), Radiation Therapy and Dosimetry (19 papers), Lung Cancer Treatments and Mutations (12 papers) and RNA Interference and Gene Delivery (11 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.2k citations), Biomaterials (1.2k citations) and Structural Biology (107 citations). Raymond M. Reilly has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Zhongli Cai, Deborah A. Scollard, Jean‐Philippe Pignol, Katherine A. Vallis, Christine Allen, Conrad Chan, Niladri Chattopadhyay, Bryan Hoang, Humphrey Fonge and Eli Lechtman. Their work appears in journals such as PLoS ONE, Cancer Research and Advanced Drug Delivery Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact